Conference Call with Slides Begins at 4:30 p.m. Eastern Time Today EMERYVILLE, Calif. / Mar 20, 2024 / Business Wire / OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three and 12 months ended December 31, 2023, and provided operating and partner program updates. “2023 was a year of significant expansion of OmniAb's partnership base and pipeline programs as we continued to execute against our plan, while... Read More

EMERYVILLE, Calif. / Feb 26, 2024 / Business Wire / OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three and 12 months ended December 31, 2023 after the close of the U.S. financial markets on Wednesday, March 20, 2024 and will hold a conference call that same day beginning at 4:30 p.m. Eastern time. Conference Call and Webcast Information What: OmniAb conference call to discuss financial results and... Read More

EMERYVILLE, Calif. / Feb 20, 2024 / Business Wire / OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in two upcoming investor conferences in March. TD Cowen 44th Annual Healthcare Conference, March 4-6, 2024, at the Marriott Copley Place in Boston, MA . Management will participate in a fireside chat on Monday, March 4 th at 11:10 a.m. Eastern time and will be available for one-on-one meetings... Read More

Introduces the functionality and benefits of the first and only transgenic chicken producing single-domain antibodies to antibody industry thought leaders and research scientists from around the world EMERYVILLE, Calif. / Dec 14, 2023 / Business Wire / OmniAb, Inc. (Nasdaq: OABI) announces the presentation of new scientific... Read More

Webcast and event slides available here EMERYVILLE, Calif. / Nov 09, 2023 / Business Wire / OmniAb, Inc. (Nasdaq: OABI) held its first Research & Technology virtual event earlier today, during which members of the management team reviewed the Company’s technology offerings and highlighted the launch of Omni dAb, the industry’s... Read More

Webcast including Research & Technology Event begins at 11:00 a.m. Eastern time today EMERYVILLE, Calif. / Nov 09, 2023 / Business Wire / OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three and nine months ended September 30, 2023, and provided operating and partner program updates. “Our business momentum has continued with the recent addition of three new partners including another global pharma... Read More

EMERYVILLE, Calif. / Nov 02, 2023 / Business Wire / OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in two upcoming investor conferences in November. Stifel 2023 Healthcare Conference, November 14-15, 2023 at the Lotte New York Palace Hotel in New York City. Management will participate in a fireside chat on Wednesday, November 15 th at 8:00 a.m. Eastern time and will be available for... Read More

EMERYVILLE, Calif. / Nov 01, 2023 / Business Wire / OmniAb, Inc. (NASDAQ: OABI) today announced the appointment of Steve Love to its Board of Directors. Mr. Love has more than 30 years of financial experience including more than 13 years serving in Chief Financial Officer positions, and will serve on OmniAb’s Audit Committee as Chair. With this appointment the OmniAb Board returns to seven directors, including five... Read More

November 9 th webcast to include a review of third quarter 2023 financial results EMERYVILLE, Calif. / Oct 31, 2023 / Business Wire / OmniAb, Inc. (Nasdaq: OABI) announces the agenda for its Research & Technology virtual event to be held on Thursday, November 9 th beginning at 11:00 a.m. Eastern time. The two-hour event will include an update on the company’s technology offerings, a review of third quarter financial results,... Read More

Webcast to include an update on latest technology offerings and third quarter 2023 financial results EMERYVILLE, Calif. / Oct 12, 2023 / Business Wire / OmniAb, Inc. (Nasdaq: OABI) today announced it will hold a virtual Research & Technology event on Thursday, November 9 beginning at 11:00 a.m. Eastern time. The event is expected to last approximately two hours and will include a review of the company’s latest technology... Read More

EMERYVILLE, Calif. / Sep 05, 2023 / Business Wire / OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in two upcoming investor conferences in September. H.C. Wainwright 25 th Annual Global Investment Conference, September 11-13, 2023 at the Lotte New York Palace Hotel in New York City. Management will deliver a company presentation on Tuesday, September 12 th at 9:00 a.m. Eastern time and will... Read More

Conference Call with Slides Begins at 4:30 p.m. Eastern Time Today EMERYVILLE, Calif. / Aug 10, 2023 / Business Wire / OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three and six months ended June 30, 2023, and provided operating and partner program updates. “Our business continued to grow and perform well during the second quarter with advancements in business development and progress across partner... Read More

EMERYVILLE, Calif. / Aug 07, 2023 / Business Wire / OmniAb, Inc. (NASDAQ: OABI) announces that Director Sunil Patel passed away suddenly last week. The Board of Directors and leadership of OmniAb extend their deepest condolences to those who loved and cared for Sunil and express their gratitude for Sunil’s many contributions to OmniAb. Sunil Patel was appointed to OmniAb’s Board in November 2022 when OmniAb was spun-out of... Read More

EMERYVILLE, Calif. / Jul 31, 2023 / Business Wire / OmniAb, Inc. (Nasdaq: OABI) will report financial results for the three and six months ended June 30, 2023 after the close of the U.S. financial markets on Thursday, August 10, 2023 and will hold a conference call that same day beginning at 4:30 p.m. Eastern time. Conference Call and Webcast Information What: OmniAb conference call to discuss financial results and business... Read More

Suite of in silico tools leverages Company’s Biological Intelligence ™ and large proprietary multi-species antibody databases to enhance the rapid identification of therapeutic candidates with optimal profiles EMERYVILLE, Calif. / May 17, 2023 / Business Wire / OmniAb, Inc. (NASDAQ: OABI) announced the launch of OmniDeep ™ at the 19 th Annual PEGS Boston Conference and Expo: The Essential Protein Engineering & Cell Therapy... Read More

Conference Call with Slides Begins at 8:30 a.m. Eastern Time Today EMERYVILLE, Calif. / May 11, 2023 / Business Wire / OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three months ended March 31, 2023, and provided operating and partner program updates. “Our first quarter performance is a strong start to the year. We reached 301 active programs, with 27 in clinical development or approved for... Read More

EMERYVILLE, Calif. / May 01, 2023 / Business Wire / OmniAb, Inc. (Nasdaq: OABI) will report financial results for the three months ended March 31, 2023 before the open of the U.S. financial markets on Thursday, May 11, 2023 and will hold a conference call that same day beginning at 8:30 a.m. Eastern time. Conference Call and Webcast Information What: OmniAb conference call to discuss financial results and business updates... Read More

EMERYVILLE, Calif. / Apr 25, 2023 / Business Wire / OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in five upcoming investor conferences in May. H.C. Wainwright BioConnect Investor Conference at NASDAQ, May 2, 2023 at Nasdaq World Headquarters, New York City. Management will be participating in a fireside chat on Tuesday, May 2 nd at 9:30 a.m. Eastern time and will be hosting one-on-one... Read More

Conference Call with Slides Begins at 4:30 p.m. Eastern Time Today EMERYVILLE, Calif. / Mar 30, 2023 / Business Wire / OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the three and 12 months ended December 31, 2022, and provided operating and partner program updates. “Following the closing of the spin-off and business combination transactions last November, OmniAb is well-positioned for continued growth by... Read More

EMERYVILLE, Calif. / Feb 07, 2023 / Business Wire / OmniAb, Inc. (NASDAQ: OABI) today announced that management will be participating in three upcoming investor conferences. SVB Securities Global Biopharma Conference, February 14-16, 2023. Management will be participating in a virtual fireside chat on Wednesday, February 15 th at 11:20 a.m. Eastern time and will be hosting one-on-one virtual meetings with investors. Cowen 43... Read More

Leading Antibody Discovery Technologies Enable Development of Innovative Therapeutics Regular-way Trading of OABI Begins November 2, 2022 on Nasdaq EMERYVILLE, Calif., November 01, 2022--(BUSINESS WIRE)-- OmniAb, Inc. (NASDAQ: OABI) today announced the completion of the expected tax-free spin-off from Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) and the subsequent business combination with Avista Public Acquisition... Read More